BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37446306)

  • 1. A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype.
    Shah R; van den Berk PCM; Pritchard CEJ; Song JY; Kreft M; Pilzecker B; Jacobs H
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.
    Koomen M; Cheng NC; van de Vrugt HJ; Godthelp BC; van der Valk MA; Oostra AB; Zdzienicka MZ; Joenje H; Arwert F
    Hum Mol Genet; 2002 Feb; 11(3):273-81. PubMed ID: 11823446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.
    Yang Y; Kuang Y; Montes De Oca R; Hays T; Moreau L; Lu N; Seed B; D'Andrea AD
    Blood; 2001 Dec; 98(12):3435-40. PubMed ID: 11719385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
    Reliene R; Yamamoto ML; Rao PN; Schiestl RH
    Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
    Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
    Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere dynamics in Fancg-deficient mouse and human cells.
    Franco S; van de Vrugt HJ; Fernández P; Aracil M; Arwert F; Blasco MA
    Blood; 2004 Dec; 104(13):3927-35. PubMed ID: 15319283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain.
    Kruyt FA; Abou-Zahr F; Mok H; Youssoufian H
    J Biol Chem; 1999 Nov; 274(48):34212-8. PubMed ID: 10567393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg.
    van de Vrugt HJ; Koomen M; Berns MA; de Vries Y; Rooimans MA; van der Weel L; Blom E; de Groot J; Schepers RJ; Stone S; Hoatlin ME; Cheng NC; Joenje H; Arwert F
    Genes Cells; 2002 Mar; 7(3):333-42. PubMed ID: 11918676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.
    Yamamoto K; Ishiai M; Matsushita N; Arakawa H; Lamerdin JE; Buerstedde JM; Tanimoto M; Harada M; Thompson LH; Takata M
    Mol Cell Biol; 2003 Aug; 23(15):5421-30. PubMed ID: 12861027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired functionality and homing of Fancg-deficient hematopoietic stem cells.
    Barroca V; Mouthon MA; Lewandowski D; Brunet de la Grange P; Gauthier LR; Pflumio F; Boussin FD; Arwert F; Riou L; Allemand I; Romeo PH; Fouchet P
    Hum Mol Genet; 2012 Jan; 21(1):121-35. PubMed ID: 21968513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
    Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
    DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.
    Munkhjargal A; Kim MJ; Kim DY; Jeon YJ; Kee YH; Kim LK; Kim YH
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Fanconi Anemia phenotypes in Fancd2 depletion mice.
    Yang Q; Xie H; Zhong Y; Li D; Ke X; Ying H; Yu B; Zhang T
    Biochem Biophys Res Commun; 2019 Jun; 514(3):713-719. PubMed ID: 31078270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
    Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
    J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
    Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
    DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
    Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
    Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.